How Endress+Hauser helps customers to improve their products and manufacture them even more efficiently.
Egypt is using a world-record-breaking plant to treat enough wastewater to develop new farmland. As the main supplier of measurement technology, Endress+Hauser ensures that every drop is precisely monitored.
With complex international projects, Endress+Hauser also handles customers’ supply chain management. From the life sciences industry comes a demonstration of the immense difference this makes.
Global supply chains are under mounting pressure from geopolitical tensions, complex regulatory landscapes, resource shortages and production bottlenecks. Endress+Hauser counters these challenges with end-to-end transparency to deliver efficiency and stability – for customers and in its own operations.
Crises, wars, pandemics: The challenges facing supply chains are enormous. We need to be bold in preparing for them, says Robert Friedmann, chairman of the Central Management Board of the Würth Group. With Matthias Altendorf, Endress+Hauser’s Supervisory Board president, he discusses the advantages of family businesses and why it ultimately all comes down to people.
Global climate protection and the associated decarbonization measures are gaining momentum. And it’s not only at the political level: as investors steer global money toward green technologies, entire industries are undergoing fundamental change. For hydrocarbon-dependent process industries, this brings both new challenges and major opportunities. We take stock of the situation.
With its three modernized seaports in Dar es Salaam, Tanga and Mtwara, Tanzania wants to reinforce its role as a major trade center in East Africa. To support this effort, Endress+Hauser is supplying advanced measurement technology – an extraordinary project that turned into a real challenge under pandemic conditions.
CureVac is a pioneer in the development and manufacture of mRNA therapeutics. The company is currently expanding its Covid-19 vaccine production – supported by Endress+Hauser.
The life science industry manager at Endress+Hauser talks about the impact of the Corona pandemic.
3 minutes
